HPGC Renmintongtai Pharmaceutical Corp - Class A

SHSE:600829 (China)   Class A
Â¥ 5.97 (+4.19%) Jun 7
11.59
P/B:
1.22
Market Cap:
Â¥ 3.46B ($ 477.65M)
Enterprise V:
Â¥ 3.56B ($ 491.65M)
Volume:
4.94M
Avg Vol (2M):
4.33M
Volume:
4.94M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for HPGC Renmintongtai Pharmaceutical Corp ( ) from 1994 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. HPGC Renmintongtai Pharmaceutical stock (SHSE:600829) PE ratio as of Jun 08 2024 is 11.59. More Details

HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) PE Ratio (TTM) Chart

To

HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) PE Ratio (TTM) Historical Data

Total 1204
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
HPGC Renmintongtai Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-08 11.6 2024-04-02 13.1
2024-06-07 11.6 2024-04-01 13.1
2024-06-06 11.1 2024-03-29 12.8
2024-06-05 11.6 2024-03-28 12.8
2024-06-04 11.9 2024-03-27 13.0
2024-06-03 12.0 2024-03-26 13.1
2024-05-31 12.4 2024-03-25 13.2
2024-05-30 12.3 2024-03-22 13.5
2024-05-29 12.4 2024-03-21 13.7
2024-05-28 12.4 2024-03-20 13.7
2024-05-27 12.7 2024-03-19 13.3
2024-05-24 12.6 2024-03-18 13.4
2024-05-23 12.7 2024-03-15 13.1
2024-05-22 13.0 2024-03-14 13.0
2024-05-21 13.0 2024-03-13 13.0
2024-05-20 13.2 2024-03-12 12.9
2024-05-17 13.1 2024-03-11 12.7
2024-05-16 13.2 2024-03-08 12.6
2024-05-15 13.3 2024-03-07 12.4
2024-05-14 13.4 2024-03-06 12.4
2024-05-13 13.2 2024-03-05 12.4
2024-05-10 13.3 2024-03-04 12.7
2024-05-09 13.5 2024-03-01 12.6
2024-05-08 13.3 2024-02-29 12.5
2024-05-07 13.4 2024-02-28 12.1
2024-05-06 13.4 2024-02-27 13.0
2024-04-30 13.0 2024-02-26 12.7
2024-04-29 12.8 2024-02-23 12.6
2024-04-26 12.5 2024-02-22 12.3
2024-04-25 12.4 2024-02-21 11.9
2024-04-24 12.3 2024-02-20 11.8
2024-04-23 12.2 2024-02-19 11.6
2024-04-22 12.1 2024-02-16 11.3
2024-04-19 12.1 2024-02-09 11.3
2024-04-18 12.0 2024-02-08 11.3
2024-04-17 12.1 2024-02-07 10.4
2024-04-16 11.3 2024-02-06 10.9
2024-04-15 12.1 2024-02-05 10.8
2024-04-12 12.7 2024-02-02 12.0
2024-04-11 12.8 2024-02-01 12.6
2024-04-10 12.8 2024-01-31 13.1
2024-04-09 13.1 2024-01-30 13.8
2024-04-08 12.8 2024-01-29 14.4
2024-04-05 13.2 2024-01-26 14.9
2024-04-03 13.2 2024-01-25 15.0

HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.